About this episode

This episode discusses recent studies on the effectiveness of Nirmatrelvir–Ritonavir for COVID-19 and antihypertensive therapy post-intracerebral hemorrhage.

Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients * Real-World Effectiveness of Nirmatrelvir–Ritonavir Against Severe Outcomes of COVID-19 in Taiwan: A Nationwide Population-Based Cohort Study Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage * Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe

Explore listener stats, chart rankings, contacts and more on the Sensible Medicine podcast page.